Capabilities

  • Patent | Myticin peptide and its use in cell regeneration

    Authors: Antonio Figueras Huerta, María Gasset Vega, Beatriz Novoa García, Magalí Rey Campos, Ricardo Mallavía Marín, Regla María Medina Gali, Alicia Martínez López

    The present invention relates to peptides derived from myticin C and to their therapeutic use, more specifically in cell and/or tissue regeneration. More detailed information can be obtained here.

     

  • Prototype | Morbidostat: Unraveling Antimicrobial Resistance

    Morbidostat is a computer-controlled continuous culture device that automatically adjusts drug concentration to maintain constant growth inhibition in microbial cultures. As bacteria acquire mutations that give them resistance against drugs, they are able to tolerate higher drug concentrations and grow faster, thus removing selective pressure, the driving force of evolution. To compensate for this, morbidostat increases drug concentration sufficiently to keep bacteria at their original growth rate, therefore maintaining selective pressure over time. This system allows for data acquisition to model microbial evolution under antimicrobial stress, optimize biocide dosage strategies and develop highly antimicrobial-resistant strains used to test the performance of new biocides, among other applications.

     

  • Patent | Andrographolide derivatives for their use in the treatment of cytokine-related inflammatory diseases

    Authors: Eva María Rivero Buceta; Cristian Smerdou Picazo; Pablo Botella Asunción; Antonio Pineda Lucena; Carla María Vidaurre Agut; Beatriz Novoa; Antonio Figueras Huertas;  Jose María Benlloch Baviera

    Andrographolide derivatives for their use in the treatment of cytokine-related inflammatory diseases . Patent pending publication.

     

  • Patent | Andrographolide derivatives for their use in the treatment of COVID-19 and associated pulmonary fibrosis

    Authors: Antonio Pineda Lucena; Carla María Vidaurre Agut; Eva María Rivero Buceta; Jose María Benlloch Baviera; Cristian Smerdou Picazo; Beatriz Novoa; Antonio Figueras Huertas; Pablo Botella Asunción

    Andrographolid derivatives for their use in the treatment of COVID-19 and associated pulmonary fibrosis. Patent pending publication.

  • Patent | Compounds having anti-inflammatory activity

    Authors: Juan Carlos Espin de Gea; Juan Carlos Morales Sánchez; Isabel Medina

    Compounds for the treatment of inflammatory processes involved in numerous diseases such as intestinal inflammatory diseases. The invention mainly refers to compounds included within a certain general formula and to the procedure to obtain them. More detailed information can be obtained here.

     

     

Active projects